Tiempo real estimado
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
2,43 USD | +2,53 % | -2,83 % | -88,24 % |
02/04 | AN2 THERAPEUTICS, INC. : JMP Securities Cambia su recomendación a compra | ZM |
28/03 | AN2 Therapeutics, Inc. informa de los resultados del ejercicio cerrado el 31 de diciembre de 2023 | CI |
Resumen de negocios
Número de empleados: 41
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Founder | - | 01/02/17 | |
Eric Easom
FOU | Founder | 56 | 01/02/17 |
Lucy Day
DFI | Director of Finance/CFO | 65 | 01/11/19 |
Paul Eckburg
CTO | Chief Tech/Sci/R&D Officer | 53 | 01/11/19 |
Jennifer Huber
LAW | General Counsel | - | - |
Josh Eizen
LAW | General Counsel | - | - |
Corporate Officer/Principal | - | 01/11/19 | |
Kevin Krause
PRN | Corporate Officer/Principal | 49 | 01/08/21 |
Annie Yoshiyama
AUD | Comptroller/Controller/Auditor | 41 | 15/09/23 |
Sanjay Chanda
PRN | Corporate Officer/Principal | 59 | 01/11/19 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Founder | 60 | 01/02/17 | |
Patricia Martin
BRD | Director/Board Member | 63 | 01/04/21 |
Melvin Spigelman
BRD | Director/Board Member | 75 | 01/02/22 |
Director/Board Member | 58 | 09/05/22 | |
Robin Readnour
BRD | Director/Board Member | 59 | 01/11/19 |
Stephanie Wong
BRD | Director/Board Member | 50 | 01/04/21 |
Kabeer Aziz
BRD | Director/Board Member | 34 | 01/11/19 |
Eric Easom
FOU | Founder | 56 | 01/02/17 |
Gilbert Marks
BRD | Director/Board Member | 66 | 01/02/20 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 29 770 375 | 22 048 825 ( 74,06 %) | 0 | 74,06 % |
Información de la empresa
Sector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-88,24 % | 70,56 M | |
+3,88 % | 43,43 mil M | |
+47,81 % | 41,69 mil M | |
+8,93 % | 41,31 mil M | |
-10,92 % | 27,14 mil M | |
+8,68 % | 25,28 mil M | |
-24,64 % | 18,47 mil M | |
+28,98 % | 12,59 mil M | |
+0,82 % | 12,33 mil M | |
+9,15 % | 11,03 mil M |
- Bolsa de valores
- Acciones
- Acción ANTX
- Empresa AN2 Therapeutics, Inc.